Key result
Polymer-free DES may offer a valuable PCI strategy for diabetic patients with CAD.
Why the study?
Does PF-DES improve outcomes in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions?
Does PF-DES improve outcomes in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions?
Polymer-free drug-eluting stents may represent a valuable strategy for diabetic patients undergoing percutaneous coronary intervention.
Answers are grounded in this paper and cite their sources.
May support polymer-free DES selection in diabetic PCI patients; extends meta-analytic evidence to this high-risk subgroup.
PF-DES could be a valuable strategy in diabetic patients with coronary artery disease undergoing percutaneous coronary interventions.
No takes yet. Share an insight, caveat, or question.
Gurgoglione et al. (2024) studied this question. Polymer-free drug-eluting stents may be a valuable strategy for diabetic patients with coronary artery disease undergoing percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: